Emisphere Technologies, Inc. (NASDAQ: EMIS)

Emisphere Technologies, Inc. (NASDAQ: EMIS), a biopharmaceutical company, is focused on utilizing its Eligen(r) Technology to uniquely deliver therapeutic molecules. Traditionally, these molecules are delivered by injection, and in many cases, are limited because of poor bioavailability, slow on-set of action or variable absorption. With Eligen(r) Technology, oral administration is possible as well other delivery pathways. For further information, visit the Company’s web site at www.emisphere.com.